Nyx Pharmaceuticals Private Limited, a active private limited company, was established on 22 July 2019 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51909CH2019PTC042632. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Harsimran Singh Kalra (Director), Ravneet Singh (Director), Ashok Kumar (Director). Past directors included Harsimran Singh Kalra, Ravneet Singh, Jitender Mohan Kalra. It holds ₹2.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Bulding No 83, Third Floor Village Raipur Kalan U.T., Chandigarh, Chandigarh, 160102.
U51909CH2019PTC042632
042632
22 July 2019
₹1.00 M
₹1.00 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Nyx Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harsimran Singh Kalra | Director | 22 Jul 2019 | Current |
| Ravneet Singh | Director | 22 Jul 2019 | Current |
| Ashok Kumar | Director | 22 Jul 2019 | Current |
| Gaurav Gabbi | Director | 22 Jul 2019 | Current |
| Jitender Mohan Kalra | Director | 23 Aug 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Jun 2025 | Past |
| Pramod Abcsdd | Director | 24 Jun 2025 | Past |
| Pramod Abcsdd | Director | 24 Jun 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nyx Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 100.46% increase. The company also saw a slight improvement in profitability, with a 4.58% increase in profit. The company's net worth Soared by an impressive increase of 21.97%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Nyx Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹25,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jun 2025 | Axis Bank Limited | ₹2.50 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Nyx Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nyx Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nyx Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Nyx Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity A charge with Axis Bank Limited amounted to Rs. 25.00 M with Charge ID 101122836 was registered on 11 Jun 2025. was completed.
Nyx Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh. was recorded as a recent event.
The activity Jitender Mohan Kalra was appointed as a Director was appointed as a Director on 23 Aug 2019 & has been associated with this company since 6 years 4 months . was completed.
Progress on Harsimran Singh Kalra was appointed as a Director was appointed as a Director on 22 Jul 2019 & has been associated with this company since 6 years 5 months . was documented.
The activity Ravneet Singh was appointed as a Director was appointed as a Director on 22 Jul 2019 & has been associated with this company since 6 years 5 months . was completed.
The CIN of Nyx Pharmaceuticals Private Limited is U51909CH2019PTC042632.
Nyx Pharmaceuticals Private Limited is headquartered at Bulding No 83, Third Floor Village Raipur Kalan U.T., Chandigarh, Chandigarh, 160102.
Nyx Pharmaceuticals Private Limited was incorporated on 22 July 2019.
The current directors of Nyx Pharmaceuticals Private Limited are
The primary industry of Nyx Pharmaceuticals Private Limited is Trade.
Nyx Pharmaceuticals Private Limited is unlisted.
The authorized capital of Nyx Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX